(Q27851971)

English

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study (English)
0 references
Alice T Shaw
0 references
José Rodrigues Pereira
0 references
Gaëlle Jeannin
0 references
Johan Vansteenkiste
0 references
Carlos Barrios
0 references
Fabio Andre Franke
0 references
Lynda Grinsted
0 references
Victoria Zazulina
0 references
Paul Smith
0 references
Ian Smith
0 references
Lucio Crinò
0 references
January 2013
0 references
14
0 references
1
0 references
38-47
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit